Targeting self-renewal mechanisms in glioblastoma cells
Mechanisms of targeting cellular self-renewal in glioblastoma
This study is looking at how some small molecules can help stop glioblastoma cells from growing by targeting a protein called BMI1, which is often found in high amounts in these tumors, and it's designed to find better treatments for people with glioblastoma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10644883 on NIH RePORTER |
What this research studies
This research investigates how certain small molecules can inhibit the self-renewal of glioblastoma cells by targeting a specific protein called BMI1, which is often overexpressed in these tumors. The researchers are using various models, including patient-derived tumor cells and organoids, to understand how these molecules work and their effects on tumor growth. By identifying the mechanisms of action and potential biomarkers for treatment response, the study aims to develop more effective therapies for glioblastoma patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who may benefit from novel therapeutic approaches targeting BMI1.
Not a fit: Patients with other types of brain tumors or those not expressing BMI1 may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted therapies that significantly improve outcomes for patients with glioblastoma.
How similar studies have performed: Other research has shown promising results in targeting BMI1 in various cancers, indicating potential for success in this approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Sabaawy, Hatim — University of Colorado Denver
- Study coordinator: Sabaawy, Hatim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.